Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management.
Kadura S, Raghu G.
Eur Respir Rev. 2021 Jun 23;30(160):210011. doi: 10.1183/16000617.0011-2021. Print 2021 Jun 30.
Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): Update on Prevalence, Risk Factors, Pathogenesis, and Therapy.
Sullivan DI, Ascherman DP.
Curr Rheumatol Rep. 2024 Dec;26(12):431-449. doi: 10.1007/s11926-024-01155-8. Epub 2024 Sep 25.
Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Koduri G, Solomon JJ.
Arthritis Rheumatol. 2023 Dec;75(12):2067-2077. doi: 10.1002/art.42640. Epub 2023 Oct 4.
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease.
Akiyama M, Kaneko Y.
Autoimmun Rev. 2022 May;21(5):103056. doi: 10.1016/j.autrev.2022.103056. Epub 2022 Feb 1.
The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease.
Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V.
Arthritis Rheumatol. 2018 Oct;70(10):1544-1554. doi: 10.1002/art.40574. Epub 2018 Sep 4.
Screening of interstitial lung disease in patients with rheumatoid arthritis: A systematic review.
Garrote-Corral S, Silva-Fernández L, Seoane-Mato D, Guerra-Rodríguez M, Aburto M, Castañeda S, Valenzuela C, Narváez J.
Reumatol Clin (Engl Ed). 2022 Dec;18(10):587-596. doi: 10.1016/j.reumae.2021.07.002. Epub 2021 Nov 11.
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis.
Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM, Johannson KA, Ryerson CJ.
Eur Respir Rev. 2023 Mar 8;32(167):220210. doi: 10.1183/16000617.0210-2022. Print 2023 Mar 31.
Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.
Matson SM, Baqir M, Moua T, Marll M, Kent J, Iannazzo NS, Boente RD, Donatelli JM, Dai J, Diaz FJ, Demoruelle MK, Hamblin MB, Mathai SK, Ryu JH, Pope K, Walker CM, Lee JS.
Chest. 2023 Apr;163(4):861-869. doi: 10.1016/j.chest.2022.11.035. Epub 2022 Dec 5.
Biomarkers of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Guo L, Wang J, Li J, Yao J, Zhao H.
Front Immunol. 2024 Oct 29;15:1455346. doi: 10.3389/fimmu.2024.1455346. eCollection 2024.
Management of interstitial lung disease associated with connective tissue disease.
Mathai SC, Danoff SK.
BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819.
